市场调查报告书
商品编码
1298009
到 2028 年经皮中枢神经系统 (CNS) 治疗市场Transdermal CNS Therapeutics to 2028 |
这份报告考察了透皮中枢神经系统 (CNS) 治疗市场,提供了市场概述、技术趋势、需求驱动因素、按细分市场划分的药物趋势以及进入市场的公司概况。我正在整理。
“Transdermal CNS Therapeutics to 2028: Products, Therapeutics, Markets and Forecasts” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector. The study is designed to provide drug company decision makers, drug delivery developers, patch designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for Transdermal patches Provider organization business managers, healthcare administrators and investors will also benefit from this study.
Transdermal CNS drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors - factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2028.